University of California San Francisco
Give to UCSF
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.
A multidisciplinary team at UCSF has significantly improved and shortened the application process for getting early-stage research off the ground.
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
Finalists presented their work to a gathering of academic and industry reviewers recently as part of UCSF's Catalyst Awards, which provides valuable pilot funding to help drive promising early-stage research.
<p>An innovative project to develop a potential therapy to treat a wide range of cancers has won a major UC San Francisco award that aims to drive promising early-stage research through the complex process of translating ideas into patient benefit.</p>
<p>A UCSF team has developed an ambitious online cardiovascular study using smartphones, with the goal of enrolling 1 million people from all over the world to improve heart health.</p>
<p>A patient in rural Uganda is diagnosed with tuberculosis but never begins treatment. In Vietnam, someone with infectious TB might never be diagnosed because the health center is too far away. Adithya Cattamanchi, MD, is working to address challenges in Uganda and Vietnam by applying techniques of <a href="http://accelerate.ucsf.edu/training/ids">implementation </a><a href="http://accelerate.ucsf.edu/training/ids">science</a>.</p>